Hyperfine Reports Record Preliminary Q3 Revenue of $6 Million, Up 53% Sequentially

Hyperfine, Inc. (NASDAQ:HYPR) has reported preliminary third-quarter 2026 revenue of approximately $6.0 million, representing a 53% increase from the previous quarter and marking a record quarterly performance for the medical device manufacturer.

The Connecticut-based company also reported a reduction in cash consumption, with preliminary net cash burn, excluding financing proceeds, expected to reach approximately $5.6 million during the three months ended 30 September 2026.

This represents a 29% improvement compared with the second quarter and marks the first time Hyperfine expects its quarterly revenue to exceed its quarterly net cash burn.

The company confirmed that it did not raise any financing proceeds during the reporting period.

Hyperfine, which develops the FDA-cleared Swoop portable magnetic resonance imaging (MRI) system for brain imaging, also reaffirmed its full-year revenue and cash burn forecasts.

The preliminary results remain unaudited and are subject to completion of the company’s quarter-end financial closing procedures.

Quarterly Revenue Growth Accompanied by Lower Cash Burn

Hyperfine’s expected third-quarter revenue of approximately $6.0 million reflects a substantial improvement from the preceding quarter.

The 53% sequential increase represents the company’s highest quarterly revenue performance to date.

At the same time, preliminary net cash burn is expected to decline to approximately $5.6 million, reflecting a 29% sequential improvement.

The combination of higher revenue and reduced cash consumption represents an important financial milestone, with quarterly sales expected to exceed net cash burn for the first time.

However, the comparison does not necessarily indicate that Hyperfine has reached profitability or achieved positive operating cash flow, as revenue and net cash burn measure different aspects of financial performance.

Maria Sainz, President and Chief Executive Officer of Hyperfine, highlighted the improvement in both revenue generation and operating efficiency.

“Preliminary expected revenue of approximately $6.0 million represents a significant step up, with 53% sequential growth, while strong operating discipline is reflected in lower cash burn,” Sainz said.

The company attributed the improved financial performance to continued revenue growth alongside efforts to manage operating expenditure.

Nine-Month Revenue Increases 66% to $13.8 Million

For the nine months ended 30 September 2026, Hyperfine expects to report preliminary revenue of approximately $13.8 million.

This represents a 66% increase compared with the corresponding period in 2025, reflecting stronger sales performance over the first three quarters of the year.

Preliminary net cash burn for the nine-month period is expected to total approximately $22.2 million, an 8% improvement year on year.

The reduction in cash consumption occurred alongside the increase in revenue, indicating progress in the company’s efforts to improve financial efficiency.

Hyperfine also provided an update on its liquidity position at the end of the third quarter.

Cash and cash equivalents are expected to total approximately $37.9 million as of 30 September 2026, compared with $43.5 million at the end of June.

The $5.6 million quarterly reduction in cash holdings was consistent with the company’s reported preliminary net cash burn, with no financing proceeds raised during the period.

The remaining cash balance provides resources for ongoing operations, although future liquidity requirements will depend on revenue growth, expenditure and financing needs.

Hyperfine Reaffirms Full-Year 2026 Financial Guidance

Following the preliminary third-quarter performance, Hyperfine maintained its financial outlook for the full year.

The company continues to expect 2026 revenue of approximately $20 million to $22 million.

At the midpoint of $21 million, this would represent growth of roughly 55% compared with full-year 2025.

Hyperfine also reaffirmed its full-year net cash burn guidance of approximately $26 million to $28 million.

The midpoint of the forecast range, $27 million, would represent a reduction of approximately 10% compared with the previous year.

The guidance reflects management’s expectations for continued revenue expansion and improved cash management during the remainder of 2026.

Achieving the full-year revenue forecast would require approximately $6.2 million to $8.2 million in fourth-quarter revenue, based on the preliminary nine-month figure.

The company has not announced any changes to its annual financial targets following the third-quarter update.

Swoop Portable MRI System Remains Central to Business

Hyperfine develops medical imaging technology, including its Swoop portable MRI system, which has received clearance from the US Food and Drug Administration for brain imaging.

The system is designed to provide magnetic resonance imaging capabilities in a portable format, offering an alternative to conventional fixed MRI installations for certain clinical applications.

Hyperfine’s business focuses on expanding the use of portable brain imaging technology while improving its financial performance.

The preliminary third-quarter results indicate stronger revenue generation, although the company continues to consume cash as it supports its commercial and operational activities.

Hyperfine expects to publish its complete third-quarter 2026 financial results on 9 November 2026.

The final report will provide additional details on revenue, expenses, profitability and cash flow once the financial closing process has been completed.

Until then, the figures announced for the third quarter and nine-month period remain preliminary and subject to adjustment.

Hyperfine stock price